VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Monday, December 29, 2025
Stock Comparison
ASM International N.V. vs Merck & Co., Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
ASM International N.V.
ASM · Euronext Amsterdam
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into ASM International N.V.'s moat claims, evidence, and risks.
View ASM analysisMerck & Co., Inc.
MRK · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Merck & Co., Inc.'s moat claims, evidence, and risks.
View MRK analysisComparison highlights
- Moat score gap: ASM International N.V. leads (74 / 100 vs 71 / 100 for Merck & Co., Inc.).
- Segment focus: ASM International N.V. has 3 segments; Merck & Co., Inc. has 2 segments (89.5% in Pharmaceutical).
- Primary market structure: Quasi-Monopoly vs Competitive. Pricing power: n/a vs Moderate.
- Moat breadth: ASM International N.V. has 5 moat types across 3 domains; Merck & Co., Inc. has 5 across 3.
Primary market context
ASM International N.V.
ALD equipment
Single-wafer atomic layer deposition (ALD) equipment for semiconductor manufacturing
Global
Semiconductor manufacturers (logic/foundry, memory)
Wafer fab equipment supplier
Merck & Co., Inc.
Pharmaceutical
Branded prescription pharmaceuticals & human vaccines
Global
Wholesalers/retailers, managed care and government payers, hospitals/clinics
R&D-intensive innovator, manufacturer, and marketer
89.5%
Side-by-side metrics
Moat coverage
Shared moat types
ASM International N.V. strengths
Merck & Co., Inc. strengths
Segment mix
ASM International N.V. segments
Full profile >ALD equipment
Quasi-Monopoly
Silicon epitaxy equipment
Oligopoly
Spares and services
Quasi-Monopoly
Merck & Co., Inc. segments
Full profile >Pharmaceutical
Competitive
Animal Health
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.